Barbiturate and Benzodiazepine Coverage Changes for Dual Eligibles under Medicare Part D Plans

 

Effective January 1, 2013, the South Carolina Department of Health and Human Services (SCDHHS) will exclude coverage for barbiturates “used in the treatment of epilepsy, cancer, or a chronic mental health disorder” and benzodiazepines for dual eligible individuals (Medicare/Medicaid).  This exclusion of coverage applies only to dual eligible individuals.

SCDHHS is implementing this change as a result of an amendment of the Medicare Improvement for Patients and Providers Act of 2008 (MIPPA).  Section 1860D-2(e) (2) (A) of MIPPA was amended to include barbiturates “used in the treatment of epilepsy, cancer, or a chronic mental health disorder” and benzodiazepines under Medicare Part D drug coverage for dual eligible individuals (Medicare/Medicaid).

Please refer any questions regarding this bulletin to the SCDHHS Provider Service Center at 1-888-289-0709.  Thank you for your continued support of the South Carolina Medicaid Program.

Report Fraud